“showed a trend”

However, the SDS/Amyloban group showed a trend toward a decrease in the mean difference in SAT after 2 weeks of amyloban treatment ( p = 0.06) (Figure 2J ).

±3.6 versus 2.9±4.5 days; adjusted P =1.0), postoperative insertion of intra‐aortic balloon pump and/or extracorporeal membrane oxygenation (3.3% versus 4.9%; adjusted P =0.1), KDIGO acute kidney injury (21.3% versus 22.8%; adjusted P =0.2) and dialysis (1.8% versus 1.8%; adjusted P =0.8), but they showed a trend toward increased risk of severe/massive bleeding (7.8% versus 6.4%; adjusted P =0.06; OR 1.284, 95% CI, 0.989–1.667).

There were no significant differences in seropositivity among males versus females; RR 1.08 (95% CI 0.58–2.01), P = 0.82, while having a link with schools (teachers or students) showed a trend to be associated with seropositivity RR 1.85 (95% CI 0.96–3.57), P = 0.06.

Uterine hyperstimulation during TOLAC showed a trend in relation to the risk of uterine rupture: OR 1.68 (95 % CI 0.97–2.89), p = 0.06.

The factors that gained significance or showed a trend ( p ≤ 0.06) were analyzed multivariate with a Cox-regression-model.

Spearman analysis showed a trend ( P = 0.06) to associate secondary infection with IL-6 (r = 0.76) and BUN (r = 0.76) (see Supplementary Table 2 ).

T1–T2) disease was specifically associated with a significantly increased risk of any recurrence or LRR (hazard ratio [HR] 3.41, p = .036 and HR 5.56, p = .029, respectively) and showed a trend for association with worse OS (HR 2.58, p = .060).

Colonic mRNA expression of IL-23 showed a trend towards a significant reduction in the Fat-1 mouse ( P = 0.06), whereas the expression of IL-23R did not differ between groups ( P = 0.95).

Correlation analyses showed a trend for a negative correlation between 8-iso and Ferriman score in women with PCOS consuming COCs (r = −0.86, p = 0.06) and a negative correlation between GSH and hyperandrogenism in women with PCOS (r = −0.89, p = 0.01).

While anti-mPD-L1×m4-1BB showed a trend of increased PFS (p=0.06 vs control), PFS was significantly extended by the combination (p<0.001 vs control).

Decreased verbal fluency (COWAT) in schizophrenia patients with elevated cytokines Performance on all cognitive tests was significantly lower in schizophrenia relative to controls (see Figure 3 , Supplementary Table 2 ) with the exception of the COWAT letter fluency (which showed a trend at P =0.06) and the Wechsler Adult Intelligence Scale–3rd edition similarities subtest.

Cortical T1 values showed a trend to be higher in the BSA group compared to the sham group (p = 0.06) ( Fig. 2B ).

However, the post hoc comparisons only showed a trend towards a difference between the DHM animals and the control group (Tukey HSD, p = 0.060; Table S2 ).

The GABA motor protein Kif5A showed a trend towards reduction in DLB compared to control ( p = 0.06, uncorrected), but no change in AD.

24 , 38 The same study showed a trend towards improvement of NPS on the UHDRS behavioral domain ( T 1,35 = 1.94, P = 0.06). 38 Open Label Studies Change in NPS composite score was a primary outcome in four open label studies. 41 , 42 , 43 , 45 All these studies reported a significant improvement of NPS (Table 3 ).

The response rate was 16% in men and 13% in women ( p = 0.80), however, men showed a trend toward a larger response size relative to women ( F = 3.60, p = 0.060).

Indeed, Kaplan—Meier survival curves ( Fig 1 ) showed a trend towards lower mortality of Δpsmα - and Δpsmαβhld -infected rabbits ( P = .06).

At 3 months, participants with schizophrenia in the intervention group reported lower perceived stress levels ( P =.04) and showed a trend for a higher perceived level of social support ( P =.06).

Multivariate analysis showed a trend (p = 0.06) of higher VPCs count, ventricular tachycardia runs and allorhythmic forms in dogs with signs of congestion.

Percentage change showed a trend towards being significantly greater in the WBV group compared to the CON group (p = 0.06).

While increased age showed a trend toward an increased risk of MACE ( P = 0.06), ( Table 4 ).

Patients with late severe respiratory complications showed a trend toward having larger LRT V 100 and V 150 ( p = 0.06 and 0.051).

Bonferroni post-hoc tests showed a trend ( p = 0.06, effect size = 0.45) for higher VO 2max values attained during the 90% VP test (3.61 ± 0.54 L/min) when compared to the ramp test (3.37 ± 0.39 L/min).

Similarly, the median circulating adiponectin also showed a trend of lower value in the cases (vs. the controls) in the nested case–control cohort (1.62 vs 2.21 μg/mL, P = 0.06) (Additional file 1 : Table S1).

FREM2|STOML3 rs4544127 showed a trend for association (p = 0.06).